miR-409-3p在肿瘤中的研究进展

doi:10.11904/j.issn.1002-3070.2020.06.014

摘要/Abstract

摘要： microRNA是一类内源性非编码小RNA,它通过与靶基因的3′端非翻译区(3′UTR)结合,在转录后上调其靶基因的表达,进而调控多种生物学过程。miR-409-3p属于microRNA家族的一员,随着研究的深入,越来越多的证据表明肿瘤中存在异常表达的miR-409-3p,其与肿瘤的发生发展及预后密切相关,在肿瘤细胞增殖、凋亡、血管生成、迁移、侵袭和耐药等过程中发挥重要作用而受到了广泛的关注,近年来其可能作为新的循环标志物而成为研究的热点。本文就miR-409-3p在肿瘤中的研究进展进行综述。

关键词: microRNA, miR-409-3p, 肿瘤, 诊断, 治疗, 预后

Abstract: microRNA is a type of endogenous non-coding small RNA.It binds to the 3′UTR of its target gene at the post-transcriptional level,thereby regulating a variety of organism process.miR-409-3p belongs to a large family of microRNA.With the deepening of research,more and more evidence shows that there is abnormal expression of miR-409-3p in tumors,which is also closely related to the occurrence,development and prognosis of tumors.miR-409-3p and has received extensive attention about its important role in various processes such as tumor cell proliferation,apoptosis,angiogenesis,migration,invasion and the development of drug resistance.In recent years,MiR-409-3p may become a research hot spot as a new circulating marker.This article reviews the research progress of miR-409-3p in tumors.

Key words: microRNA, miR-409-3p, Tumor, Diagnosis, Treatment, Prognosis

中图分类号:

左蕊, 金路, 刘丽, 刘小嘉, 赵鹏宇, 向小燕. miR-409-3p在肿瘤中的研究进展[J]. 实用肿瘤学杂志, 2020, 34(6): 554-559.

ZUO Rui, JIN Lu, LIU Li, LIU Xiaojia, ZHAO Pengyu, XIANG Xiaoyan. Research progress of miR-409-3p and tumor[J]. Journal of Practical Oncology, 2020, 34(6): 554-559.

0
/ / 推荐

导出引用管理器 EndNote|Reference Manager|ProCite|BibTeX|RefWorks

链接本文: http://journal09.magtechjournal.com/Jwk3_syzlxzz/CN/10.11904/j.issn.1002-3070.2020.06.014

http://journal09.magtechjournal.com/Jwk3_syzlxzz/CN/Y2020/V34/I6/554

参考文献

1 Venkatadri R,Muni T,Iyer AK,et al.Role of apoptosis-related miRNAs in resveratrol-induced breast cancer cell death[J].Cell Death Dis,2016,7:e2104.
2 Cao GH,Sun XL,Wu F,et al.Low expression of miR-409-3p is a prognostic marker for breast cancer[J].Eur Rev Med Pharmacol Sci,2016,20(18):3825-3829.
3 Ma Z,Li Y,Xu J,et al.MicroRNA-409-3p regulates cell invasion and metastasis by targeting ZEB1 in breast cancer[J].IUBMB Life,2016,68(5):394-402.
4 Zhang G,Liu Z,Xu H,et al.miR-409-3p suppresses breast cancer cell growth and invasion by targeting Akt1[J].Biochem Biophys Res Commun,2016,469(2):189-195.
5 Cuk K,Zucknick M,Madhavan D,et al.Plasma microRNA panel for minimally invasive detection of breast cancer[J].PLoS One,2013,8(10):e76729.
6 Shen J,Hu Q,Schrauder M,et al.Circulating miR-148b and miR-133a as biomarkers for breast cancer detection[J].Oncotarget,2014,5(14):5284-5294.
7 Zhao Z,Yang F,Liu Y,et al.MicroRNA-409-3p suppresses cell proliferation and cell cycle progression by targeting cyclin D2 in papillary thyroid carcinoma[J].Oncol Lett,2018,16(4):5237-5242.
8 Kim YW,Kim EY,Jeon D,et al.Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells[J].Drug Des Devel Ther,2014,8:293-314.
9 Cheng Y,Ban R,Liu W,et al.MiRNA-409-3p enhances cisplatin-sensitivity of ovarian cancer cells by blocking the autophagy mediated by Fip200[J].Oncol Res,2018,10.
10 Gharpure KM,Pradeep S,Sans M,et al.FABP4 as a key determinant of metastatic potential of ovarian cancer[J].Nat Commun,2018,9(1):2923.
11 Zhang S,Zhang X,Fu X,et al.Identification of common differentially-expressed miRNAs in ovarian cancer cells and their exosomes compared with normal ovarian surface epithelial cell cells[J].Oncol Lett,2018,16(2):2391-2401.
12 Sommerova L,Anton M,Bouchalova P,et al.The role of miR-409-3p in regulation of HPV16/18-E6 mRNA in human cervical high-grade squamous intraepithelial lesions[J].Antiviral Res,2019,163:185-192.
13 Shukla V,Varghese VK,Kabekkodu SP,et al.Enumeration of deregulated miRNAs in liquid and tissue biopsies of cervical cancer[J].Gynecol Oncol,2019,155(1):135-143.
14 申利,魏军成.miRNA-409-3p表达水平对宫颈癌细胞增殖及顺铂化疗敏感性的影响[J].实用肿瘤学杂志,2019,33(4):300-304.
15 Li C,Nie H,Wang M,et al.MicroRNA-409-3p regulates cell proliferation and apoptosis by targeting PHF10 in gastric cancer[J].Cancer Lett,2012,320(2):189-197.
16 邓应君.MiR-409-3p抑制胃癌侵袭转移机制及MiR-202在慢性粒细胞白血病化疗敏感中作用的研究[D].广州:广州医科大学,2018.
17 Zheng B,Liang L,Huang S,et al.MicroRNA-409 suppresses tumour cell invasion and metastasis by directly targeting radixin in gastric cancers[J].Oncogene,2012,31(42):4509-4516.
18 杨素冰,张相良.高精度腹腔灌注化疗患者血清中miR-409-3p表达水平与胃癌预后的关系[J].分子影像学杂志,2016,39(3):257-259.
19 Bai R,Weng C,Dong H,et al.MicroRNA-409-3p suppresses colorectal cancer invasion and metastasis partly by targeting GAB1 expression[J].Int J Cancer,2015,137(10):2310-2322.
20 Liu M,Xu A,Yuan X,et al.Downregulation of microRNA-409-3p promotes aggressiveness and metastasis in colorectal cancer:an indication for personalized medicine[J].J Transl Med,2015,13:195.
21 D′Angelo E,Fassan M,Maretto I,et al.Serum miR-125b is a non-invasive predictive biomarker of the pre-operative chemoradiotherapy responsiveness in patients with rectal adenocarcinoma[J].Oncotarget,2016,7(19):28647-2857.
22 Tan S,Shi H,Ba M,et al.miR-409-3p sensitizes colon cancer cells to oxaliplatin by inhibiting Beclin-1-mediated autophagy[J].Int J Mol Med,2016,37(4):1030-1038.
23 Wang S,Xiang J,Li Z,et al.A plasma microRNA panel for early detection of colorectal cancer[J].Int J Cancer,2015,136(1):152-161.
24 Zhang J,Raju GS,Chang DW,et al.Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer[J].Cancer,2018,124(4):785-796.
25 Josson S,Gururajan M,Hu P,et al.miR-409-3p/-5p promotes tumorigenesis,epithelial-to-mesenchymal transition,and bone metastasis of human prostate cancer[J].Clin Cancer Res,2014,20(17):4636-4646.
26 Yu Q,Li P,Weng M,et al.Nano-vesicles are a potential tool to monitor therapeutic efficacy of carbon ion radiotherapy in prostate cancer[J].J Biomed Nanotechnol,2018,14(1):168-178.
27 Josson S,Gururajan M,Sung SY,et al.Stromal fibroblast-derived miR-409 promotes epithelial-to-mesenchymal transition and prostate tumorigenesis[J].Oncogene,2015,34(21):2690-2699.
28 Xu X,Chen H,Lin Y,et al.MicroRNA-409-3p inhibits migration and invasion of bladder cancer cells via targeting c-Met[J].Mol Cells,2013,36(1):62-68.
29 Xu X,Zhu Y,Liang Z,et al.c-Met and CREB1 are involved in miR-433-mediated inhibition of the epithelial-mesenchymal transition in bladder cancer by regulating Akt/GSK-3β/Snail signaling[J].Cell Death Dis,2016,7:e2088.
30 Lian J,Lin SH,Ye Y,et al.Serum microRNAs as predictors of risk for non-muscle invasive bladder cancer[J].Oncotarget,2018,9(19):14895-14908.
31 Zhu J,Ma X,Zhang Y,et al.Establishment of a miRNA-mRNA regulatory network in metastatic renal cell carcinoma and screening of potential therapeutic targets[J].Tumour Biol,2016[Epub ahead of print].
32 Wang Y,He Y,Bai H,et al.Phosphoinositide-dependent kinase 1-associated glycolysis is regulated by miR-409-3p in clear cell renal cell carcinoma[J].J Cell Biochem,2019,120(1):126-134.
33 Rapa I,Votta A,Felice B,et al.Identification of microRNAs differentially expressed in lung carcinoid subtypes and progression[J].Neuroendocrinology,2015,101(3):246-255.
34 Wan L,Zhu L,Xu J,et al.MicroRNA-409-3p functions as a tumor suppressor in human lung adenocarcinoma by targeting c-Met[J].Cell Physiol Biochem,2014,34(4):1273-1290.
35 Qu R,Chen X,Zhang C.lncRNA ZEB1-AS1/miR-409-3p/ZEB1 feedback loop is involved in the progression of non-small cell lung cancer[J].Biochem Biophys Res Commun,2018,507(1-4):450-456.
36 徐佳灵,喻松霞,金柏军,等.miR-409-3p靶向癌基因ELF2抑制非小细胞肺癌细胞系A549增殖[J].基础医学与临床,2019,39(11):1592-1596.
37 Li YB,Lin LZ,Guan JS,et al.TCM combined western medicine treatment of advanced NSCLC:a preliminary study of mIRNA expression profiles[J].Zhongguo Zhong Xi Yi Jie He Za Zhi,2016,36(9):1076-1081.
38 Zhou X,Wen W,Shan X,et al.A six-microRNA panel in plasma was identified as a potential biomarker for lung adenocarcinoma diagnosis[J].Oncotarget,2017,8(4):6513-6525.
39 Zhang J,Hou W,Jia J,et al.MiR-409-3p regulates cell proliferation and tumor growth by targeting E74-like factor 2 in osteosarcoma[J].FEBS Open Bio,2017,7(3):348-357.
40 Wu S,Du X,Wu M,et al.MicroRNA-409-3p inhibits osteosarcoma cell migration and invasion by targeting catenin-δ1[J].Gene,2016,584(1):83-89.
41 Wu L,Zhang Y,Huang Z,et al.MiR-409-3p inhibits cell proliferation and invasion of osteosarcoma by targeting zinc-finger E-box-binding homeobox-1[J].Front Pharmacol,2019,10:137.
42 Cao Y,Zhang L,Wei M,et al.MicroRNA-409-3p represses glioma cell invasion and proliferation by targeting high-mobility group nucleosome-binding domain 5[J].Oncol Res,2017,25(7):1097-1107.
43 Khalil S,Fabbri E,Santangelo A,et al.miRNA array screening reveals cooperative MGMT-regulation between miR-181d-5p and miR-409-3p in glioblastoma[J].Oncotarget,2016,7(19):28195-28206.
44 Kumar A,Nayak S,Pathak P,et al.Identification of miR-379/miR-656(C14MC)cluster downregulation and associated epigenetic and transcription regulatory mechanism in oligodendrogliomas[J].J Neurooncol,2018,139(1):23-31.
45 Zhi F,Shao N,Li B,et al.A serum 6-miRNA panel as a novel non-invasive biomarker for meningioma[J].Sci Rep,2016,6:32067.
46 Weng C,Dong H,Chen G,et al.miR-409-3p inhibits HT1080 cell proliferation,vascularization and metastasis by targeting angiogenin[J].Cancer Lett,2012,323(2):171-179.
47 Chen H,Dai J.miR-409-3p suppresses the proliferation,invasion and migration of tongue squamous cell carcinoma via targeting RDX[J].Oncol Lett,2018,16(1):543-551.
48 Leivonen SK,Icay K,Jäntti K,et al.MicroRNAs regulate key cell survival pathways and mediate chemosensitivity during progression of diffuse large B-cell lymphoma[J].Blood Cancer J,2017,7(12):654.
49 Kim K,Yoo D,Lee HS,et al.Identification of potential biomarkers for diagnosis of pancreatic and biliary tract cancers sequencing of serum microRNAs[J].BMC Med Genomics,2019,12(1):62.

[1]	文洪梅, 陈杨, 石青萍, 任思颖, 高娇, 秦明芳. 2016年云南省肿瘤登记地区恶性肿瘤的发病和死亡分析[J]. 实用肿瘤学杂志, 2020, 34(6): 485-490.
[2]	相智声, 马晶昱, 钟文玲, 陈铁晖, 林永添, 江惠娟, 周衍. 福建省2016年恶性肿瘤发病与死亡分析[J]. 实用肿瘤学杂志, 2020, 34(6): 491-494.
[3]	孙晓凯, 刘付东, 梁季, 郑春早, 周金意. 江苏省盐城市2008—2018年消化道肿瘤死亡情况及其变化趋势分析[J]. 实用肿瘤学杂志, 2020, 34(6): 495-499.
[4]	牛明, 于歌. 促进乳腺癌增殖转移和肿瘤干细胞特征的研究[J]. 实用肿瘤学杂志, 2020, 34(6): 518-523.
[5]	白怡冰, 杨佳妮, 方琳, 张艳桥. 野生型胃肠道间质瘤的研究进展[J]. 实用肿瘤学杂志, 2020, 34(6): 524-529.
[6]	李建昕, 沈彬杰, 王璇. 恶性肿瘤社区随访模式的研究进展[J]. 实用肿瘤学杂志, 2020, 34(6): 540-543.
[7]	陈敏, 刘莉萍, 张玲. iTRAQ技术在消化道肿瘤研究中的应用进展[J]. 实用肿瘤学杂志, 2020, 34(6): 549-553.
[8]	石琳娜, 隋红. 原发性肝癌免疫检查点抑制剂治疗的进展与挑战[J]. 实用肿瘤学杂志, 2020, 34(6): 560-564.
[9]	宋家羽, 冯越, 王棹, 张云艳. 外泌体与妇科恶性肿瘤相关性的最新研究进展[J]. 实用肿瘤学杂志, 2020, 34(6): 571-575.
[10]	刘恒昌, 魏然, 李春香, 刘正, 陈海鹏, 关旭, 赵志勋, 邹霜梅, 王锡山, 姜争. NOX4在结肠癌组织中的表达及与预后的关系[J]. 实用肿瘤学杂志, 2020, 34(5): 391-397.
[11]	孙小艳, 张晓艳. LncRNA-SChLAP1在结直肠癌组织中高表达的预后评估意义[J]. 实用肿瘤学杂志, 2020, 34(5): 425-429.
[12]	尹松祥. Copine-8在胃癌组织中的表达与临床病理特征及预后的相关性[J]. 实用肿瘤学杂志, 2020, 34(5): 430-435.
[13]	卢江岳, 张建鑫, 葛晓峰. 鼻咽癌同步推量同步放化疗与常规分割后缩野同步放化疗的疗效及毒性反应对比分析[J]. 实用肿瘤学杂志, 2020, 34(5): 440-445.
[14]	李爽, 金世柱. 人工智能在内镜诊断上消化道早癌领域的研究进展[J]. 实用肿瘤学杂志, 2020, 34(5): 471-475.
[15]	赵颖欣, 秦玲. 二甲双胍与多发性骨髓瘤的研究进展[J]. 实用肿瘤学杂志, 2020, 34(5): 476-479.